1. EP-1090: Particle therapy and IMRT for patients with esthesioneuroblastoma: a single-institution experience. (May 2017) Authors: Liermann, J.; Syed, M.; Bernhardt, D.; Bougatf, N.; Harrabi, S.B.; Paul, A.; Sprave, T.; Rieken, S.; Haberer, T.; Herfarth, K.; Debus, J.; Hauswald, H.; Adeberg, S. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx. (November 2018) Authors: Hauswald, H.; Jensen, A.D.; Krauss, J.; Haselmann, R.; Lossner, K.; Hartmann, S.; Windemuth-Kieselbach, C.; Münter, M.W.; Debus, J. Journal: Clinical and translational radiation oncology Issue: Volume 13(2018) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗